Letter: Diagnostic index for premyxoedema

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026

Photobiomodulation therapy combined with a static magnetic field for chronic non-specific knee pain: protocol for a multicentre, randomised, triple-blind, placebo-controlled trial.

BMJ open·2026

Complete Pachydermoperiostosis With Acromegaloid Phenotype: Characteristic 99mTc-Methylene Diphosphonate (MDP) Skeletal Scintigraphy in a Rare Clinical Mimic of Acromegaly.

Clinical nuclear medicine·2026

Dermatofibrosarcoma protuberans following penetrating trauma: Case report.

Radiology case reports·2026

Potential Clinical Impact of Revised Pulmonary Hypertension Definitions at Moderate Altitude.

CHEST pulmonary·2026

PSMA-avid Pleural Solitary Fibrous Tumor Incidentally Detected on [18F] Piflufolastat PSMA PET/CT.

Clinical nuclear medicine·2026

Related Experiment Videos

Letter: Diagnostic index for premyxoedema

Related Concept Videos

Decrease in cardiac output and muscle sympathetic activity during vasovagal syncope.

A comparison of post-prandial changes in flow-mediated dilatation in patients with type 2 diabetes with and without macroalbuminuria.

Effects of omapatrilat on systemic arterial function in patients with chronic heart failure.

The clinical, cardiac, renal, arterial and neurohormonal effects of omapatrilat, a vasopeptidase inhibitor, in patients with chronic heart failure.

Brain stem stroke causing baroreflex failure and paroxysmal hypertension.

Baroreceptor denervation presenting as part of a vagal mononeuropathy.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Low alkaline phosphatase in adults: implications for the diagnosis of hypophosphatasia during evaluation for osteoporosis.

Photobiomodulation therapy combined with a static magnetic field for chronic non-specific knee pain: protocol for a multicentre, randomised, triple-blind, placebo-controlled trial.

Complete Pachydermoperiostosis With Acromegaloid Phenotype: Characteristic 99mTc-Methylene Diphosphonate (MDP) Skeletal Scintigraphy in a Rare Clinical Mimic of Acromegaly.

Dermatofibrosarcoma protuberans following penetrating trauma: Case report.

Potential Clinical Impact of Revised Pulmonary Hypertension Definitions at Moderate Altitude.

PSMA-avid Pleural Solitary Fibrous Tumor Incidentally Detected on [18F] Piflufolastat PSMA PET/CT.

Related Experiment Videos

Letter: Diagnostic index for premyxoedema

Related Concept Videos

Related Articles